Revaccination With PNEUMOVAX™ 23 in Older Japanese Adults (V110-902)

Clinical trial NCT02260882 · COMPLETED

Trial details

NCT number: NCT02260882
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Pneumococcal Infection

Start date: 2014-10-31
Primary completion: 2015-04-09
Enrollment: 243

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.